Azenta (NASDAQ:AZTA) Hits New 52-Week High Following Strong Earnings

Key Points

• Azenta shares reached a new 52-week high of $47.72 after reporting quarterly adjusted EPS of $0.28, beating the $0.11 analyst estimate, and revenue of $167.09 million, above the $160.16 million consensus.
• For fiscal 2027, the company forecast revenue of $648 million–$660 million, above analyst expectations, and projected 3%–5% organic growth with adjusted EBITDA margin expansion of about 200–250 basis points.
• Rosen Law Firm is investigating potential securities claims related to allegations of misleading business information; the inquiry raises legal and reputational uncertainty but is not a finding of wrongdoing.

Shares of Azenta, Inc. (NASDAQ:AZTA - Get Free Report) hit a new 52-week high during trading on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $47.72 and last traded at $47.4580, with a volume of 204,979 shares changing hands. The stock had previously closed at $40.48.

The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.17. The firm had revenue of $167.09 million for the quarter, compared to analysts' expectations of $160.16 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.

Top Azenta Stories

Here are a few of the latest stories about AZTA:

• Positive Sentiment: For fiscal Q4 2026, Azenta reported adjusted EPS of $0.28, versus analysts’ $0.11 estimate, and revenue of $167.09 million, above the $160.16 million consensus. Revenue grew 5% year over year as reported and 2% organically. Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026
• Positive Sentiment: Fiscal 2027 revenue guidance of $648 million to $660 million is above the $632.4 million consensus. Azenta also expects 3%–5% organic revenue growth and adjusted EBITDA margin expansion of about 200–250 basis points, signaling expectations for continued growth and improved profitability. Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026
• Negative Sentiment: Rosen Law Firm said it is investigating potential securities claims tied to allegations that Azenta may have provided materially misleading business information. The inquiry could create legal and reputational uncertainty, but the announcement describes allegations, not a finding of misconduct. Rosen Law Firm investigation announcement

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on AZTA shares. Wall Street Zen lowered Azenta from a "buy" rating to a "hold" rating in a report on Sunday, October 18th. Weiss Ratings raised Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, August 26th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $37.00 price target on shares of Azenta in a research report on Monday, September 14th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $41.20.

Institutional Trading of Azenta

Hedge funds have recently bought and sold shares of the company. Global Retirement Partners LLC boosted its holdings in shares of Azenta by 82.3% during the third quarter. Global Retirement Partners LLC now owns 771 shares of the company's stock worth $27,000 after purchasing an additional 348 shares during the period. Heritage Family Offices LLP acquired a new position in Azenta in the 3rd quarter valued at approximately $31,000. State of Wyoming acquired a new position in Azenta in the 1st quarter valued at approximately $38,000. Integrated Wealth Concepts LLC purchased a new stake in Azenta in the 2nd quarter worth approximately $39,000. Finally, Allworth Financial LP purchased a new stake in Azenta in the 2nd quarter worth approximately $48,000. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Stock Performance

The business's 50 day simple moving average is $35.64 and its 200-day simple moving average is $28.47. The company has a market cap of $2.08 billion, a price-to-earnings ratio of -17.18 and a beta of 1.47.

Azenta Company Profile

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.